Study of somatrogon for pediatric growth hormone deficiency in India
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at how well somatrogon works for children 3 years and older with growth hormone deficiency. It may help you understand if this treatment is an option for your child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 3 years old or older with pediatric growth hormone deficiency.
- Your child must be prescribed somatrogon by their doctor.
- You or your child must sign a consent form agreeing to take part.
- Your child must not be in any other clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This trial is looking at how well Sogroya® (a growth hormone medicine) works when used for a long time in children with short stature caused by growth hormone deficiency. The goal is to see if it helps them grow taller safely.
This study tests different doses of a long-acting growth hormone medicine to see which works best for children who are shorter than expected for their age. It may help improve growth in both early and later stages of puberty.
This trial tests if a new weekly growth hormone shot (somatrogon) works as well as a daily one (Genotropin) for children who are short because they were born small or have no clear cause.
This study tracks the safety of lonapegsomatropin in children being treated for growth hormone deficiency (GHD). It’s meant to check for side effects and make sure the medicine continues to be safe in real-world use.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
Hear when a new Dwarfism, Pituitary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.